NCT00067158

Brief Summary

The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
585

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Apr 2003

Shorter than P25 for phase_3

Geographic Reach
1 country

13 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2003

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2003

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 13, 2003

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2004

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2004

Completed
Last Updated

January 12, 2017

Status Verified

April 1, 2010

Enrollment Period

1.3 years

First QC Date

August 12, 2003

Last Update Submit

January 11, 2017

Conditions

Tobacco Use Disorder

Keywords

nicotine dependence

Outcome Measures

Primary Outcomes (2)

  • Drug use

  • Smoking Cessation

Interventions

nicotine transdermal systemDRUG

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is alcohol or drug dependent, in Outpatient Drug-Free or Opiate Substitute program and is interested in quitting smoking

You may not qualify if:

  • Patient is psychotic
  • Use of smokeless tobacco
  • Use of other smoking cessasation product
  • Pregnancy
  • Patient has hyper-tension, heart problems, or skin condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Matrix Institute on Addictions

Los Angeles, California, 90016, United States

Location

Tarzana Treatment Center

Tarzana, California, 91356, United States

Location

SPECTRUM

Miami, Florida, 33156, United States

Location

Center for Drug Free Living

Orlando, Florida, 32805, United States

Location

Chelsea Arbor Addictions Treatment Center

Ann Arbor, Michigan, 48103, United States

Location

Psychiatry and Behavioral Medicine Professionals I

Detroit, Michigan, 48207, United States

Location

Narco Freedom (Bridge Plaza)

Long Island City, New York, 11101, United States

Location

St. Luke's Roosevelt Hospital Center

New York, New York, 10019, United States

Location

St. Luke's Roosevelt Hospital Center, Womens

New York, New York, 10025, United States

Location

Mount Sinai Medical Center

New York, New York, 10029, United States

Location

Piedmont Behavioral Healthcare

Concord, North Carolina, 28001, United States

Location

Coastal Horizons Center, Inc.

Wilmington, North Carolina, 28412, United States

Location

Behavioral Health Services of Pickens County

Pickens, South Carolina, 29671, United States

Location

Related Links

MeSH Terms

Conditions

Tobacco Use Disorder

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Malcolm Reid, Ph.D.

    New York University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Purpose
TREATMENT
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 12, 2003

First Posted

August 13, 2003

Study Start

April 1, 2003

Primary Completion

July 1, 2004

Study Completion

July 1, 2004

Last Updated

January 12, 2017

Record last verified: 2010-04

Locations

US(13)